長期投資家のためのIR情報
バリュートレンド

【2191】テラ 〔上場廃止〕
ー(上場廃止)免疫細胞医療。

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2022.12 2022/05/13 当初予 27 - - - -640 - - - -638 - - - -639 - - -
2021.12 2022/02/14 106 - - - -794 - - - -792 - - - -948 - - -
2020.12 2021/02/15 76 - - - -1,089 - - - -1,099 - - - -1,067 - - -
2019.12 2020/02/13 202 0.0% -63.2% -716 -0.1% +19.1% -773 0.0% +19.2% -1,026 -0.1% -6.9%
2019.12 2020/02/07 修正予 202 -15.5% -63.2% -715 -1.0% +19.2% -773 0.0% +19.2% -1,025 -0.4% -6.8%
2019.12 2019/11/11 Q3予 239 0.0% -56.5% -708 0.0% +20.0% -773 0.0% +19.2% -1,021 0.0% -6.4%
2019.12 2019/08/13 Q2予 239 -56.5% -56.5% -708 +20.0% +20.0% -773 +19.2% +19.2% -1,021 -6.4% -6.4%
2019.12 2019/05/13 Q1予 549 0.0% 0.0% -885 0.0% 0.0% -957 0.0% 0.0% -960 0.0% 0.0%
2019.12 2019/02/15 当初予 549 - - - -885 - - - -957 - - - -960 - - -
2018.12 2019/02/15 516 +1.2% +1.2% -685 +35.4% +35.4% -755 +32.3% +32.3% -929 +17.1% +17.1%
2018.12 2018/11/14 Q3予 510 0.0% 0.0% -1,060 0.0% 0.0% -1,115 0.0% 0.0% -1,120 0.0% 0.0%
2018.12 2018/10/15 Q2予 510 0.0% 0.0% -1,060 0.0% 0.0% -1,115 0.0% 0.0% -1,120 0.0% 0.0%
2018.12 2018/05/11 Q1予 510 0.0% 0.0% - - - - -1,115 0.0% 0.0% -1,120 0.0% 0.0%
2018.12 2018/02/13 当初予 510 - - - -1,060 - - - -1,115 - - - -1,120 - - -
2017.12 2018/02/13 957 +0.7% -44.4% -245 -22.5% -345.0% -261 -13.5% -426.3% -643 -7.2% -83.7%
2017.12 2017/11/10 Q3予 950 0.0% -44.8% -200 0.0% -300.0% -230 0.0% -387.5% -600 0.0% -71.4%
2017.12 2017/11/09 修正予 950 -30.7% -44.8% -200 -66.7% -300.0% -230 -53.3% -387.5% -600 -66.7% -71.4%
2017.12 2017/08/10 Q2予 1,370 -20.3% -20.3% -120 -220.0% -220.0% -150 -287.5% -287.5% -360 -2.9% -2.9%
2017.12 2017/05/12 Q1予 1,720 0.0% 0.0% 100 0.0% 0.0% 80 0.0% 0.0% -350 0.0% 0.0%
2017.12 2017/02/14 当初予 1,720 - - - 100 - - - 80 - - - -350 - - -
2016.12 2017/02/14 1,801 -2.6% -12.2% -621 -38.0% -96.5% -667 -41.9% -103.4% -918 -66.9% -163.0%
2016.12 2016/11/11 Q3予 1,850 0.0% -9.8% -450 0.0% -42.4% -470 0.0% -43.3% -550 0.0% -57.6%
2016.12 2016/08/12 Q2予 1,850 -9.8% -9.8% -450 -42.4% -42.4% -470 -43.3% -43.3% -550 -57.6% -57.6%
2016.12 2016/05/13 Q1予 2,052 0.0% 0.0% -316 0.0% 0.0% -328 0.0% 0.0% -349 0.0% 0.0%
2016.12 2016/02/09 当初予 2,052 - - - -316 - - - -328 - - - -349 - - -
2015.12 2016/02/09 1,909 -1.9% -14.0% -601 +11.7% -64.7% -623 +12.4% -76.5% -990 -36.4% -159.8%
2015.12 2015/11/10 Q3予 1,945 0.0% -12.4% -681 0.0% -86.6% -711 0.0% -101.4% -726 0.0% -90.6%
2015.12 2015/08/07 Q2予 1,945 -12.4% -12.4% -681 -86.6% -86.6% -711 -101.4% -101.4% -726 -90.6% -90.6%
2015.12 2015/05/01 Q1予 2,221 0.0% 0.0% -365 0.0% 0.0% -353 0.0% 0.0% -381 0.0% 0.0%
2015.12 2015/02/13 FY予 2,221 0.0% 0.0% -365 0.0% 0.0% -353 0.0% 0.0% -381 0.0% 0.0%
2015.12 2015/02/06 当初予 2,221 - - - -365 - - - -353 - - - -381 - - -
2014.12 2015/02/13 1,865 0.0% -10.8% -293 0.0% -117.0% -330 0.0% -111.5% -402 0.0% -161.0%
2014.12 2015/02/06 1,865 -8.6% -10.8% -293 +7.3% -117.0% -330 +6.0% -111.5% -402 -24.1% -161.0%
2014.12 2014/11/07 Q3予 2,040 0.0% -2.4% -316 0.0% -134.1% -351 0.0% -125.0% -324 0.0% -110.4%
2014.12 2014/08/05 Q2予 2,040 0.0% -2.4% -316 0.0% -134.1% -351 0.0% -125.0% -324 0.0% -110.4%
2014.12 2014/08/01 修正予 2,040 -2.4% -2.4% -316 -134.1% -134.1% -351 -125.0% -125.0% -324 -110.4% -110.4%
2014.12 2014/05/02 Q1予 2,090 0.0% 0.0% -135 0.0% 0.0% -156 0.0% 0.0% -154 0.0% 0.0%
2014.12 2014/02/07 当初予 2,090 - - - -135 - - - -156 - - - -154 - - -
2013.12 2014/02/07 1,539 0.0% 0.0% 23 0.0% 0.0% -24 0.0% 0.0% -58 0.0% 0.0%
2013.12 2014/01/31 当初予 1,539 - - - 23 - - - -24 - - - -58 - - -
ページトップへ戻る